FindTrial
Sign In

Advanced MRI In Parkinsons Disease.

Role Of DTI In Parkinsonian Disorders.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023136
Enrollment
196
Registered
2020-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G258- Other specified extrapyramidal andmovement disorders Health Condition 2: G20- Parkinsons disease Health Condition 3: G219- Secondary parkinsonism, unspecified

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinically diagnosed Parkinsons disease, Multisystem atrophy, Dementia of Lewy body.

Exclusion criteria

Exclusion criteria: Patients with vascular causes of parkinsons disease. patients with structural brain anormalities, seizures. patients with history of alcohol/ drug abuse. patients with major physical/ neuropsychiatric disorders. other contraindications for MRI.

Design outcomes

Primary

MeasureTime frame
DTI Parameters - FA Will Be Correlated With Clinical Severity- ie UPDRS Motor Score (0-56) Modified Hoehn And Hahr Scoring (1 TO 5).Timepoint: Outcome Will Be Achieved At The End Of The Study.—

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE—

Countries

India

Contacts

Public ContactJeshvin B

Kasturba Medical College, Manipal

docprakashinik@yahoo.co.in9845053325

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026